Vaping Explained: What We Know, What We Don’t, and Where We’re Headed

Photo of author
Written By Cecilia Camille

I'm a mother of four and a writer who loves to blog, write, and be involved in online communities. I have experience with parenting as well as technology-related work. In fact, I've always been interested in how technology impacts the world around us.

Vaping, once a niche phenomenon, has become a widespread practice spanning multiple countries, age groups, and socioeconomic backgrounds. Over the last decade, e-cigarettes, once strange, futuristic devices, have evolved into a multibillion-dollar global market.

Today, vape shops dot many city streets, online retailers offer an array of sleek devices and flavored liquids, and public health officials debate the role these products should play in reducing harm to adult smokers.

With so much conflicting information, it’s no wonder many people feel uncertain about what vaping is, how it differs from smoking, what the risks and benefits might be, and where the science stands on this relatively new technology.

This article takes a deep look at vaping. We’ll clarify how vaping works, outline the known health impacts, jump into the reasons why some health organizations consider it a potential harm-reduction tool, and explore the controversies around youth use and regulation.

We’ll also highlight what major studies and respected institutions say and discuss how evolving research may shape the future of this rapidly changing field.

Understanding What Vaping Is

Vaping refers to the use of electronic cigarettes (often called e-cigarettes, vapes, or vape pens) or other electronic nicotine delivery systems (ENDS).

Instead of burning tobacco, these devices heat a liquid, commonly called “e-liquid” or “vape juice,” that typically contains nicotine, flavorings, and other additives.

When heated, the liquid turns into an aerosol (commonly referred to as vapor) that users inhale. This fundamental difference matters: by heating a liquid rather than igniting tobacco leaves, vaping generally avoids the thousands of harmful combustion byproducts found in cigarette smoke.

While all vapes work on the same principle, heating a liquid solution to produce an inhalable aerosol, there is tremendous variation in device design, size, power, and complexity. Early models resembled cigarettes and were called “cigalikes,” but modern variants include sleek, pen-style devices and advanced box mods that allow users to adjust power, temperature, and airflow.

As technology progressed, e-liquids began to come in a wide array of flavors, including fruit, dessert, and menthol options, contributing to a diverse user experience that appeals to different tastes.

The Rising Popularity of Vaping

The popularity of vaping has soared since the early 2010s. According to Euromonitor International, the global e-cigarette market has grown exponentially, and millions of adult smokers have tried vaping products. Surveys conducted in countries like the United Kingdom and the United States show that many adults use vapes as an alternative to conventional cigarettes.

Public Health England has reported that many smokers switch to vaping to reduce the health risks associated with burning tobacco. The convenience of buying online, the existence of specialized vape shops, and the presence of vaping communities and forums have all contributed to the growth of this market.

Vaping vs. Smoking: The Core Differences

The primary distinction between vaping and smoking lies in combustion. Traditional cigarettes involve lighting tobacco leaves on fire, creating smoke that contains tar, carbon monoxide, and thousands of other toxic and carcinogenic chemicals. According to the U.S. Centers for Disease Control and Prevention (CDC), this toxic mix is responsible for the well-known health consequences of smoking, including heart disease, lung cancer, and chronic obstructive pulmonary disease (COPD).

Vaping does not involve combustion. Instead, it relies on heating a fluid that contains nicotine (derived from tobacco but isolated from the leaf and not burned).

Major health organizations, such as the Royal College of Physicians (RCP) in the UK and Public Health England (PHE), have noted that because vaping avoids combustion, it can drastically reduce exposure to many harmful chemicals found in cigarette smoke. In 2015, PHE released a groundbreaking report suggesting that e-cigarettes are likely about 95% less harmful than smoking, a figure often cited in debates around harm reduction.

However, it’s crucial to understand that “less harmful” does not mean “harmless.” While the absence of combustion removes many of the most dangerous toxins, vapes still contain nicotine, which is addictive, and other chemicals that require ongoing study.

The Health Impact of Vaping: What Research Says

Research on vaping is still developing compared to the extensive body of evidence on smoking, which has been studied for decades. Nonetheless, an increasing number of studies and systematic reviews are helping shape our understanding of the potential health risks and benefits of e-cigarettes.

1. Toxicant Exposure Studies:

Research published in journals such as Tobacco Control and Nicotine & Tobacco Research has demonstrated that people who switch completely from smoking to vaping show significant reductions in biomarkers of harmful substances. For example, studies have found that switching to e-cigarettes leads to lower levels of carcinogens like nitrosamines. Compared to continued smoking, exclusive vaping tends to expose users to far fewer harmful and cancer-causing chemicals.

2. Short-Term Respiratory Effects:

Short-term studies have shown that many smokers who switch to vaping experience improvements in lung function and respiratory symptoms. Trials have indicated reductions in coughing and wheezing after moving away from cigarettes.

However, researchers note that more long-term studies are needed to confirm whether these improvements persist and to fully understand vaping’s long-term impact on the lungs.

3. Cardiovascular Effects:

While initial data suggest that vaping is less hazardous to the heart and blood vessels than smoking, nicotine itself can constrict blood vessels and raise blood pressure. A 2019 review published in the Journal of the American College of Cardiology found that while e-cigarettes are likely safer than smoking for the cardiovascular system, more research is required to assess their role in heart health over decades.

4. Lung Injuries and EVALI Outbreak (2019):


In 2019, the U.S. witnessed an outbreak of e-cigarette or vaping product use-associated lung injury (EVALI). The CDC identified vitamin E acetate, an additive found primarily in illicit THC vaping liquids, as a prime culprit.

This event underscored the importance of quality control and regulation in the vaping industry. It also highlighted that not all vaping products are equal, products purchased from unregulated sources pose higher risks. Following these findings, hospitalizations decreased, illustrating that proper controls and avoiding illicit products can reduce such acute risks.

Vaping as a Harm Reduction Tool

The concept of harm reduction recognizes that while abstinence from all nicotine products might be the ideal goal, it’s not always immediately achievable for every smoker.

Many who find it difficult to quit nicotine completely may move to vaping as a stepping stone. By providing nicotine without combustion, e-cigarettes can help reduce the health risks associated with tobacco.

Public Health Endorsements and Cautions:

Public Health England and the Royal College of Physicians have both noted that e-cigarettes can serve as a less harmful option for adults who smoke. The Cochrane Collaboration, an independent network known for high-quality systematic reviews, concluded that nicotine-containing e-cigarettes can increase the chances of quitting smoking compared to nicotine-free versions or standard nicotine replacement therapies (NRTs) like patches or gum.

Another study published in the New England Journal of Medicine found that e-cigarettes were more effective than conventional NRTs in helping smokers quit, though many users continued vaping at one-year follow-up, indicating that while it may help stop smoking, it may not always lead to complete nicotine abstinence.

This perspective does not come without caveats. Public health experts emphasize that e-cigarettes are for adult smokers seeking a less harmful alternative and not for non-smokers or youth.

More data is still needed on the long-term effects of e-cigarettes. While switching completely from smoking to vaping likely reduces risk, dual-use (vaping and smoking concurrently) may lessen those benefits.

Youth Vaping: A Controversy That Shapes Policy

A significant controversy around vaping involves its appeal to young people. In the United States, for instance, the CDC and the Food and Drug Administration (FDA) have raised alarms about surging youth vaping rates that started a few years ago. Adolescents and young adults have been drawn to flavored e-liquids, marketing that seemed youth-friendly, and the perception that vaping is “safer than smoking.”

Public health officials worry that introducing a new generation of nicotine through e-cigarettes could lead to lifelong addiction or even a transition to conventional smoking.

While some experts argue that vaping prevents youth from starting to smoke cigarettes, others stress that any increase in nicotine use among adolescents is unacceptable. This debate has led to tighter regulations, flavor bans in some countries, and age verification controls.

In the UK, stricter enforcement and a public health approach that frames vaping as a tool for adult smokers rather than a lifestyle product have led to fewer concerns about youth epidemics compared to the US. Still, policymakers worldwide watch youth trends closely and adjust regulations to prevent e-cigarettes from undermining decades of progress in reducing tobacco initiation among young people.

Regulation and Quality Control

The rapid growth of the vaping market initially outpaced regulation in many countries. Today, regulators like the FDA in the US and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK are working to ensure that vaping products meet safety and quality standards.

This involves requiring companies to submit applications demonstrating that their products are appropriate for the protection of public health, setting maximum nicotine concentrations, banning certain additives, and enforcing age restrictions.

These regulatory frameworks serve multiple purposes:

  1. Protecting Youth: By setting age limits, imposing marketing restrictions, and banning flavored products appealing to children, regulators aim to minimize youth interest and uptake.
  2. Ensuring Product Safety: Standards for manufacturing and testing can prevent contamination, mislabeling, and the inclusion of harmful ingredients.
  3. Guiding Public Understanding: Balanced policies help the public understand that while vaping can be a harm reduction tool for smokers, it is not risk-free.

In the European Union, the Tobacco Products Directive (TPD) sets rules for e-cigarette product safety and quality, including child-resistant packaging, maximum nicotine levels, and the disclosure of ingredients. These regulations, coupled with ongoing research, help maintain product standards and reduce consumer risks.

The Flavor Debate

Flavors are a hallmark of the vaping experience and a key reason why some smokers find vaping more appealing than nicotine gums or patches. Surveys and qualitative studies have shown that adult smokers often credit flavored e-liquids for helping them switch away from cigarettes. They argue that flavors help distance the taste from tobacco and make the transition easier, potentially increasing their chances of quitting.

However, flavors have also come under scrutiny. Some argue that certain sweet or candy-like flavors attract young people. Public health organizations differ on how to handle this issue.

While some call for a complete flavor ban to protect youth, others suggest a middle ground, restricting marketing and access to minors while allowing adult smokers to benefit from the variety flavors offer. This tension highlights the delicate balance policymakers must strike: support adult harm reduction without encouraging youth experimentation.

The Role of Medical and Public Health Organizations

Over time, various influential bodies have contributed to the public conversation on vaping:

  • World Health Organization (WHO): The WHO takes a cautious stance, noting that more research is needed to fully understand the long-term health effects and encourage strict regulation, especially to prevent youth uptake.
  • Public Health England (PHE): PHE has been more open to supporting vaping as a harm reduction strategy, consistently stating that while not risk-free, e-cigarettes present substantially lower risks than cigarettes and can be part of smoking cessation strategies.
  • U.S. FDA and CDC: These agencies have focused heavily on regulating the industry, preventing youth access, and continuing to fund research to clarify the long-term health implications. Their stance balances potential harm reduction benefits for adult smokers with the need to prevent a new generation from becoming addicted to nicotine.
  • Cochrane Collaboration and Major Journals: Systematic reviews and research published in the New England Journal of Medicine, JAMA, and other leading journals continue shaping the conversation. Over time, their analyses help refine understanding, guide policies, and inform best practices for smoking cessation programs.

Future Directions: Research and Technology

The vaping landscape is constantly changing as technology advances and new research emerges. Companies continue to develop new devices that aim to deliver nicotine more efficiently with fewer harmful byproducts.

Innovations may include advanced temperature controls, improved wicking materials, and safer battery designs. Tobacco harm reduction advocates also monitor “heat-not-burn” products, which heat tobacco leaves at lower temperatures than cigarettes, producing an aerosol with fewer chemicals than traditional smoke.

On the research front, scientists have been conducting longer-term studies to track health outcomes among vapers for many years. These studies will help clarify the impact on cardiovascular and respiratory systems and cancer risk. The pace of ongoing research suggests that in the coming years, we’ll have a clearer picture of vaping’s place in public health strategies. Regulators, too, will likely continue refining rules based on what evidence shows, aiming to protect vulnerable populations, ensure product safety, and provide a path for adult smokers looking to reduce harm.

Practical Tips for Smokers Considering Vaping

For adults who currently smoke and are thinking about vaping as a way to reduce or quit smoking, experts suggest the following:

  1. Seek Reliable Products: Purchase from reputable vape shops or authorized sellers to ensure product quality and authenticity. Avoid black-market or untested liquids.
  2. Choose Appropriate Nicotine Levels: Many e-liquids come in varying nicotine strengths. Starting with a level that replaces the nicotine from cigarettes may help manage cravings. Over time, some users slowly reduce their nicotine level.
  3. Get Professional Advice: Speaking with a healthcare provider who understands smoking cessation can provide personalized guidance. Some doctors and cessation clinics are open to discussing vaping as one possible tool among many.
  4. Monitor Health and Progress: Pay attention to how you feel. Some people experience improved breathing and fewer coughs after switching from smoking. If you decide to move beyond vaping, gradually lowering nicotine levels may help you become nicotine-free in the future.

Final Thoughts

Vaping remains a topic filled with nuance, promise, and controversy. While it clearly differs from smoking and appears to produce fewer harmful chemicals, it is not without risks. Its value as a harm reduction tool hinges on the user, specifically adult smokers, who could benefit from a less harmful alternative to cigarettes. At the same time, serious concerns about youth use, addiction, and long-term health effects shape how public health officials, researchers, and policymakers think about these products.

As research continues, the future of vaping policy and practice will depend on a careful balancing act. The central question remains: how do we maximize potential benefits for adult smokers while minimizing risks, especially for young people and non-smokers? Finding the right answers will take more data, open minds, and thoughtful regulations. In the meantime, being informed, cautious, and aware of reliable sources can help anyone interested in vaping navigate this evolving landscape.